- WHO lists China's Sinopharm COVID-19 vaccine for emergency use
- Pfizer, BioNTech to help vaccinate athletes at 2020 Tokyo Games
- Korea develops world's first vest-like hybrid brace for scoliosis patients
- A*STAR, Hummingbird Bio announce partnership for cancer immunotherapy in Singapore
- WHO, Germany launch global hub for pandemic intelligence
- Veeva OpenData expands into Singapore to empower Pharma companies
- The Biofactory to augment enhanced care facilities in Singapore hospitals
- WuXi Biologics completed three acquisitions to enhance its global network
- Taiwan tunes to innovative hospital service flow design to enhance efficiency
- Korea brings world's first pancreatic beta cell regeneration to cure diabetes
- Malaysia's IHH Healthcare completes divestment of Apollo Gleneagles Hospital
- Singapore conducts landmark study for early detection of liver cancer
- Korea's Soulbrain Holdings picks bio-healthcare industry as engine for growth
- Australia gives major boost to COVID-19 vaccination programme
-
Contract Manufacturing | 06 May 2021 | Influencers
The APAC markets have great potential that is best cultivated from within the region : Oskar Gold
" Germany- based Vetter, one of the global leaders in prefilled drug-delivery systems, has announced the ...Read more
Specials | 07 April 2021 | Influencers
China and India... to play a vital role in supplying COVID-19 vaccines globally
1. What are the other contributions Avantor is making to fight this pandemic, particularly in APAC? &...Read more
-
Europe | 17 February 2021 | News
Merck designs sustainability framework offering data-driven insights
Merck, a leading science and technology company, has launched an enhanced Design for Sustainability (Df...Read more
-
World | 12 February 2021 | News
GenScript receives FDA EUA to use cPass test in convalescent plasma screening
GenScript USA Inc., the world's leading life science research tools and services provider, announced today tha...Read more
World | 10 February 2021 | News
Globally 128 million COVID-19 vaccine doses administered so far, updates WHO
WHo at a media briefing on Feb 10, 2021, updated that globally around 128 million vaccine doses administered s...Read more
-
Australia | 12 February 2021 | News
Australia offers revolutionary new treatment for antibiotic resistance
SuperTrans Medical (STM), a biopharmaceutical company developing novel antibiotics that target difficult-to-tr...Read more
-
World | 11 January 2021 | News
PerkinElmer to acquire Oxford Immunotec for $591M
PerkinElmer, Inc. and Oxford Immunotec Global PLC have reached an agreement on terms under which Per...Read more
FAKE DRUGS BOOM PUMMELS PHARMA INDUSTRY
Fake pharmaceuticals are continuing to flood into clinics and hospitals across Asia despite monitored regulations in China and India, when suppliers crossing the border to less-regulated countries. Counterfeiters are moving across certain less regulated locations in Southeast Asia to sustain the trade. Pharmaceutical industry is committed and thriving to sustain and secure the legitimate supply chain. Given the complexity of the supply chain, this is an essential, but laborious effort that requires an efficient, multi- faceted strategy. A holistic approach comprising the use of concealed and unconcealed anti-counterfeiting features, a well-regulated, secure supply chain and appropriate laws and penalties to deter and punish counterfeiters is necessary to provide maximum patient protection.
For Feedback Email Us : communications@biospectrumasia.com
